LETTER TO EDITOR
|Year : 2014 | Volume
| Issue : 4 | Page : 259-260
Letter to the Editor concerning Bhandari et al. "Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers"
Maria Grazia Ruo Redda1, Alessia Reali1, Simona Allis1, Silvia Maria Anglesio1, Roberta Verna1, Lavinia Bianco2
1 Department of Clinical and Biological Sciences, University of Torino, Ospedale S. Luigi Gonzaga, Orbassano, Torino, Italy
2 Department of Oncology, Radiation Oncology Unit, S. Giovanni Battista Hospital, University of Turin, Torino, Italy
|Date of Web Publication||12-Nov-2014|
Maria Grazia Ruo Redda
Department of Clinical and Biological Sciences, University of Torino, Ospedale S. Luigi Gonzaga, Orbassano, Torino. Regione Gonzole 10, 10043 Orbassano, Torino
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Ruo Redda MG, Reali A, Allis S, Anglesio SM, Verna R, Bianco L. Letter to the Editor concerning Bhandari et al. "Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers". J Med Phys 2014;39:259-60
|How to cite this URL:|
Ruo Redda MG, Reali A, Allis S, Anglesio SM, Verna R, Bianco L. Letter to the Editor concerning Bhandari et al. "Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers". J Med Phys [serial online] 2014 [cited 2020 Jul 3];39:259-60. Available from: http://www.jmp.org.in/text.asp?2014/39/4/259/144496
Since only a few studies have been published on this topic, we have read with great interest the article of Bhandari and colleagues titled "Impact of repeat computerized tomography (CT) replans in the radiation therapy of head and neck cancers",  which highlights an important problem for radiation oncologists. In this paper, the authors investigated the importance of repeating CT scan and replanning during a course of head and neck intensity modulated radiation therapy (HN-IMRT), combined with concurrent chemotherapy (CC), in order to reduce the discrepancies between planned and delivered dose to planning target volume (PTV) and organs at risk (OARs) due to radiotherapy volume and anatomical changes.
As they explain in the introduction, using IMRT to treat HN cancer patients, it is extremely important to detect anatomical changes occurring during the treatment because, as dose gradients between the target volumes and OARs are very high, they can lead to inappropriate dose coverage of the volumes and/or OARs, resulting in a possible cause of marginal recurrence or toxicity.
In this study, the authors compared volumetric and dosimetric parameters of the two different IMRT plans in 15 selected advanced HN cancer patients: an "Actual Plan" (AP), which was generated on the second CT scan (performed after the third week of the treatment), and a "Hybrid Plan" (HP) obtained by applying the original plan to the second CT scan.
The findings on the analyzed data showed a reduction of mean dose (Dmean) and PTV coverage on HP, and a statistically significant increase in median dose (Dmean) of both parotid glands (PGs) and maximum dose (Dmax) for spinal cord and brainstem on HP compared to AP, confirming the dosimetric benefit of replanning. 
In our recently preliminary published data,  volumetric and positional changes of PTVs and OARs were analyzed in 10 HN cancer patients treated with IMRT ± CC, using consecutive off-board CT scans at 3, 5 and 7 weeks during treatment in a department of Radiation Oncology not equipped with in-room Image-Guided Radiation Therapy (IGRT).
Reference planning CT study and the newly acquired CT image sets were co-registered with mutual information modality. Automatic transfer of both target volumes and OARs from planning CT to each subsequent CT scans was then performed. Based on some literature data,  in our study, dosimetric aspects were not investigated and target volumes were not re-delineated upfront during IMRT even if a shrinkage of gross tumor volume (GTV) was achieved.
In our series, apart from two patients in whom replanning was needed due to body weight loss > 5%, the results evidenced only a decrease of PG volume with a trend in volume reduction for ipsilateral irradiated PG. No significant shifts of PTVs (mean relative shift < 0.1 cm) and PGs, or spinal cord at C1 and C6 level was detected, and the collected data demonstrated a trend in external skin contours volume loss, with a mean reduction less than 5% for all patients. Similar considerations are confirmed by other authors' previous results. ,
Literature data demonstrated that significant weight loss is often correlated with positional shift of target volume and it is extremely important to detect it before volume changes can affect dose distribution to PTV or OARs.  However, comparing with our results, Bhandari et al. recorded a high incidence of weight loss, with 40% of patients requiring feeding tube and a new immobilization device, while in our series only 2 patients (20%) had a significant weight loss (> 5%) leading to replacement of thermoplastic mask and mandatory replanning.
It may be argued that in our analysis dosimetric parameters were not investigated on repeat CT scans: in our preliminary results, we recorded a PTV mean shift < 0.1 cm; therefore, taking into account the safety margin of PTVs, no significant dosimetric differences were expected in relation to that shift. Wu et al. conducted a study on 11 HN cancer patients to evaluate the difference between the planned and the delivered dose distribution in order to investigate planning margin and to define optimal planning strategies. The authors concluded that replanning was not necessary for adapting tumors to volumetric changes because no significant dosimetric modifications of the target volume were observed. 
Regarding the timing of rescanning, on the basis of literature and of our small experience, the most appropriate timing for rescanning seems to be, as still reported by Bhandari  et al., at the third week of IMRT course, although Yan et al., in a recent paper, indicated that the most appropriate replanning time is after 20 fractions of treatment. 
Finally, a controversial and still open issue concerns if a new dosimetric study is always necessary for all HN cancer patients. Capelle et al.  showed little benefit in replanning in definitive treatment, and none in adjuvant setting.
In conclusion, because "adaptive" RT remains extremely time-consuming, as stated by Yan et al.,  "criteria are urgently needed for determining which patients need replanning during IMRT and when," based on a larger sample of HN cancer patients.
| References|| |
Bhandari V, Patel P, Gurjar OP, Gupta KL. Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers. J Med Phys 2014;39:164-8.
Reali A, Anglesio SM, Mortellaro G, Allis S, Bartoncini S, Ruo Redda MG. Volumetric and positional changes of planning target volumes and organs at risk using computed tomography imaging during intensity-modulated radiation therapy for head-neck cancer: An "old" adaptive radiation therapy approach. Radiol Med 2014;119:714-20.
Eisbruch A, Gregoire V. Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. Semin Radiat Oncol 2009;19:43-52.
Ricchetti F, Wu B, McNutt T, Wong J, Forastiere A, Marur S, et al
. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011;80:161-8.
Castadot P, Geets X, Lee JA, Christian N, Grégoire V. Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiother Oncol 2010;95:209-17.
Wu Q, Chi Y, Chen PY, Krauss DJ, Yan D, Martinez A. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 2009;75:924-32.
Yan D, Yan S, Wang Q, Liao X, Lu Z, Wang Y. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: A prospective observational study. BMC Cancer 2013;13:548.
Capelle L, Mackenzie M, Field C, Parliament M, Ghosh S, Scrimger R. Adaptive radiotherapy using Helical Tomotherapy for head and neck cancer in definitive and post-operative settings: initial results. Clin Oncol (R Coll Radiol) 2012;24:208-15.